| Continuous administration results in increased bone turnover and decreased bone mineral content, increase in Testosterone secretion may cause flares in Prostatic Tissue Growth, Ovarian Cysts may occur. Not recommended in patients with Pituitary Tumours, Retreatment in Endometriosis is not recommended, since safety beyond 6 months is not established, Nasal Decongestant for Rhinitis if used should be atleast 2 hours after Nafarelin. |